Cancer Free. Since day one, these two words have driven UF Health Proton Therapy Institute to deliver the most advanced radiation treatment available, bringing the hope of a cancer-free future to pancreatic cancer patients and their families.
While some pancreatic cancers can be successfully treated with a combination of surgery, chemotherapy and radiation, traditional forms of radiation can sometimes prove problematic. That's because the organs that surround the pancreas – including the small intestine, kidneys, spinal cord and stomach – cannot withstand high doses of radiation.
Thanks to the highly precise nature of proton therapy for pancreatic cancer, however, the radiation dose is concentrated at the site of the pancreatic cancer, sparing other healthy organs exposure to radiation, and decreasing the risk of side effects.
And, since higher doses of radiation can be delivered to the pancreas with a lower risk of damage to other organs, the chance of destroying the pancreatic cancer is potentially greater.
See How Proton Therapy for Pancreatic Cancer Works
DID YOU KNOW?
Early patient outcomes in clinical research studies show proton therapy can reduce or eliminate gastrointestinal side effects as compared with conventional radiation.
UF Health Proton Therapy Cancer Experts
As a major non-profit academic medical center, the University of Florida Health Proton Therapy Institute has treated more than 12,000 patients and led the way for innovative cancer care in the Southeast U.S. since 2006. As an academic health center, our published research is setting the standards for proton therapy cancer care worldwide, with dozens of clinical trials and more than 350 published research articles in peer-reviewed journals.
When you become a patient at the UF Health Proton Therapy Institute, you are assured of receiving the highest quality cancer care as measured by state and national standards. We are committed to delivering the best possible patient outcomes. Our 125+ employees are dedicated to delivering proton cancer treatment in a way that takes the entire patient into account, so you can keep living life to the fullest.
Additional Pancreatic Cancer Research
Nichols RC, Huh S, Li Z, Rutenberg M. Proton therapy for pancreatic cancer. World J Gastrointest Oncol. 2015 Sep 15;7(9):141-7. doi: 10.4251/wjgo.v7.i9.141. Review. PubMed PMID: 26380057; PubMed Central PMCID: PMC4569591.
Lee RY, Nichols RC Jr, Huh SN, Ho MW, Li Z, Zaiden R, Awad ZT, Ahmed B, Hoppe BS. Proton therapy may allow for comprehensive elective nodal coverage for patients receiving neoadjuvant radiotherapy for localized pancreatic head cancers. J Gastrointest Oncol. 2013 Dec;4(4):374-9. doi: 10.3978/j.issn.2078-6891.2013.043. PubMed PMID: 24294509; PubMed Central PMCID: PMC3819780.
Nichols RC Jr, Huh SN, Prado KL, Yi BY, Sharma NK, Ho MW, Hoppe BS, Mendenhall NP, Li Z, Regine WF. Protons offer reduced normal-tissue exposure for patients receiving postoperative radiotherapy for resected pancreatic head cancer. Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):158-63. doi: 10.1016/j.ijrobp.2011.05.045. Epub 2012 Jan 13. PubMed PMID: 22245197.
Are you a candidate for Proton Therapy?
To learn more about proton therapy and cancer care, please fill out the form below:
Virtual consultations are subject to state and insurance approval.
To learn more about your treatment options, please complete the form on this page.
Learn more about proton therapy.
